Other OTC Pharmaceuticals (Pharmacies) - Oman

  • Oman
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$62.71m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.17%, resulting in a market volume of US$66.45m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$13.31 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Oman is experiencing steady growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Oman are driving the growth of the industry. Customers in Oman prefer to purchase over-the-counter pharmaceutical products from pharmacies due to the convenience and accessibility they offer. Pharmacies provide a wide range of OTC products that cater to various health needs, such as pain relief, cough and cold remedies, and skincare products. Customers appreciate the expertise and guidance provided by pharmacists, who can recommend suitable OTC products based on their symptoms or health conditions. This personalized approach to healthcare is highly valued by customers in Oman. Trends in the market further contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Oman. One significant trend is the increasing demand for natural and herbal OTC products. Customers are becoming more health-conscious and are seeking natural remedies for common health issues. Pharmacies in Oman are responding to this trend by offering a wide range of natural and herbal OTC products, such as herbal supplements and traditional remedies. This trend is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Oman. The country has a well-established healthcare system with a strong emphasis on primary care. Pharmacies are an integral part of this system, serving as the first point of contact for many patients seeking healthcare advice and treatment. The government of Oman has implemented policies to ensure the availability and affordability of essential OTC pharmaceutical products in pharmacies, which further supports the growth of the market. Underlying macroeconomic factors contribute to the overall growth of the Other OTC Pharmaceuticals (Pharmacies) market in Oman. The country has a stable economy with a growing middle class and increasing disposable income. This enables individuals to afford OTC pharmaceutical products and contributes to the demand for such products. Additionally, Oman has a young population, which is more likely to seek OTC remedies for common health issues. The combination of a stable economy, increasing disposable income, and a young population creates a favorable environment for the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Oman. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Oman is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility of pharmacies, along with the personalized guidance provided by pharmacists, are driving customer preferences. The increasing demand for natural and herbal OTC products, the emphasis on primary care in the healthcare system, and government policies further contribute to the growth of the market. The stable economy, increasing disposable income, and young population in Oman create a favorable environment for the development of the Other OTC Pharmaceuticals (Pharmacies) market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)